GKIM
AVNS

GW&K Investment Management’s Avanos Medical AVNS Stock Holding History

GW&K Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19
Closed -$1K – 475
2022
Q4 		$1K Buy
+19
New +$465 ﹤0.01% 413
2019
Q2 		– Sell
-5,431
Closed -$232K – 339
2019
Q1 		$232K Buy
5,431
+15
+0.3% +$672 ﹤0.01% 297
2018
Q4 		$243K Buy
5,416
+30
+0.6% +$1.57K ﹤0.01% 268
2018
Q3 		$369K Buy
+5,386
New +$347K 0.01% 261
2018
Q2 		– Sell
-4,920
Closed -$227K – 289
2018
Q1 		$227K Buy
+4,920
New +$234K ﹤0.01% 281

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GW&K Investment Management's AVNS Position: Q1 2023 in Review

GW&K Investment Management sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 19 shares — an estimated $1K sold.

GW&K Investment Management first reported a position in AVNS in Q1 2018 and held it in 5 quarters. The position peaked at $369K in Q3 2018. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

  • GW&K Investment Management reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
  • GW&K Investment Management sold 19 Avanos Medical shares in Q1 2023, an estimated $1K.
  • GW&K Investment Management first reported a position in Avanos Medical in Q1 2018 and held it in 5 quarters.
  • GW&K Investment Management's Avanos Medical position peaked at $369K in Q3 2018.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on GW&K Investment Management's 13F filing for Q1 2023, filed 9 May 2023.